Logo

James Watson and the Holy Grail

May 11, 2009

James Watson speaks with the UK's Telegraph about his quest for the "holy grail" of neuroscience, to use genetic research to uncover the cause of mental disorders and use that to treat and cure them. He says he is motivated by his son Rufus' schizophrenia, which has led him to be hospitalized, and Watson says that the decreasing cost of sequencing will make this work "feasible and affordable."

Filed under

Research & Discovery
Neurological & Psychological Disorders
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.